{"schema_version":"secwatch.filing_event.v1","accession":"0001819790-22-000045","form_type":"8-K","ticker":"TARS","cik":"0001819790","company_name":"Tarsus Pharmaceuticals, Inc.","filed_at":"2022-12-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.320392+00:00","generated_at":"2026-06-21T08:16:45.010937+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Tarsus Pharma board chair Ackermann resigns; CEO Azamian succeeds; Yarno named lead independent director","bullets":["Michael Ackermann resigned as Chairperson and Board member effective Dec 2, 2022; no disagreement with company.","Ackermann entered a 12-month consulting agreement, receiving 5,000 RSUs vesting in one year and continued equity vesting.","CEO Bobak Azamian appointed Board Chairperson effective Dec 2; will not receive additional compensation.","Wendy Yarno appointed Lead Independent Director effective Dec 2; granted 5,000 RSUs vesting in one year and $75,000 annual cash retainer."],"urls":{"canonical":"https://secwatch.observer/filing/0001819790-22-000045","json":"https://secwatch.observer/filing/0001819790-22-000045.json","markdown":"https://secwatch.observer/filing/0001819790-22-000045.md","text":"https://secwatch.observer/filing/0001819790-22-000045.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819790/000181979022000045/0001819790-22-000045-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819790/000181979022000045/tars-20221201.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T08:16:45.010937+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1c183f3b18","claim":"Michael Ackermann resigned as Chairperson of the Board at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"Michael Ackermann, the Chairperson of the Board of Directors (the “Board”) of Tarsus Pharmaceuticals, Inc. (the “Company”) notified the Company of his resignation as the Chairperson and as a member of the Board and any committees of the Board, effective December 2, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979022000045/0001819790-22-000045-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairperson of the Board"}],"fact_type":"executive_change"},{"claim_id":"bfa9d70c89","claim":"Wendy Yarno was appointed as Lead Independent Director at Tarsus Pharmaceuticals, Inc..","evidence_excerpt":"and Wendy Yarno, current member of the Board, as Lead Independent Director, each appointment effective as of December 2, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1819790/000181979022000045/0001819790-22-000045-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Lead Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}